[ad_1]
The U.S. Medicines Agency announced Thursday that it is working on changes to the recommendations regarding the Pfizer / BioNTech vaccine against Covid-19, following allergic reactions in two people who received an injection in the country, writes AFP.
One of these two vaccinated caregivers in Alaska had a severe or “anaphylactic” reaction that required hospitalization.
“These people have been treated appropriately and luckily they are cured or on the way to being cured.”said Doran Fink, of the Vaccines Office of the US Medicines Agency, during a meeting of the Advisory Committee for the authorization of another vaccine, Moderna.
The US authorities are in contact with the UK authorities, who also use the Pfizer vaccine, to better understand these cases.
“All current data continues to justify the Pfizer vaccine without further restrictions, but these cases” emphasize the need to remain vigilant during the first phase of the vaccination campaign, “said Doran Fink.
To this end, “the US Drug Agency is working with Pfizer to continue making changes to vaccine recommendations and prescriptions to draw attention to CDC (Center for Disease Control and Prevention) guidelines. of Diseases) for post-vaccination follow-up and management of allergic reactions immediately, “he explained.
These changes will include the warning that is already in effect for people who have a history of allergies to vaccine products to avoid vaccination for now.
Vaccination facilities must also ensure that treatment for severe allergic reactions is readily available.
These warnings will also apply to the Moderna vaccine if it is approved by the U.S. Drug Administration.
The two remedies use a new technology, called messenger RNA (mRNA), that was not approved in a vaccine before Pfizer.
